Syndax Pharmaceuticals (SNDX) Research & Development (2015 - 2026)
Syndax Pharmaceuticals (SNDX) posted Research & Development of $68.04 million for Q2 2026, up 9.3% from $62.23 million a year earlier and up 15.6% from the prior quarter.
Powered by 
Analysis
Syndax Pharmaceuticals (SNDX) Research & Development (2015 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Syndax Pharmaceuticals was $261.8 million, up 0.6% year-over-year; for FY2025, it was $258.78 million, up 7.1% from FY2024.
- Annual Research & Development has increased for six consecutive years, with a five-year compound annual growth rate of 38.7% (FY2020 to FY2025).
- In prior years, Syndax Pharmaceuticals' Research & Development was $241.65 million in FY2024 (+48.2%), $163.03 million in FY2023 (+37.6%), $118.5 million in FY2022 (+34.3%) and $88.25 million in FY2021 (+75.0%).
- Quarterly Research & Development has run from a low of $23.9 million in Q4 2021 to a high of $78.64 million in Q4 2025 over five years.
- On a year-over-year basis, Research & Development increased in six of the last eight quarters, with growth averaging 17.7%.
- The strongest year-over-year quarter for Research & Development in the past five years was Q3 2024, with growth of 81.6%; the weakest was Q3 2025, with a decline of 20.7%.
- According to Business Quant data, Research & Development for the three prior quarters was $58.85 million (Q1 2026), $78.64 million (Q4 2025) and $56.28 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Syndax Pharmaceuticals | 1.59 Bn | -137.74 Mn | 69.58 Mn | 68.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 68.04 Mn |
| Mar 31, 2026 | 58.85 Mn |
| Dec 31, 2025 | 78.64 Mn |
| Sep 30, 2025 | 56.28 Mn |
| Jun 30, 2025 | 62.23 Mn |
| Mar 31, 2025 | 61.64 Mn |
| Dec 31, 2024 | 65.53 Mn |
| Sep 30, 2024 | 70.97 Mn |
| Jun 30, 2024 | 48.66 Mn |
| Mar 31, 2024 | 56.49 Mn |
| Dec 31, 2023 | 55.13 Mn |
| Sep 30, 2023 | 39.09 Mn |
| Jun 30, 2023 | 34.76 Mn |
| Mar 31, 2023 | 34.05 Mn |
| Dec 31, 2022 | 31.84 Mn |
| Sep 30, 2022 | 26.90 Mn |
| Jun 30, 2022 | 29.73 Mn |
| Mar 31, 2022 | 30.02 Mn |
| Dec 31, 2021 | 23.90 Mn |
| Sep 30, 2021 | 25.61 Mn |
API Access
Syndax Pharmaceuticals Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=SNDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "SNDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=SNDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();